Realising milestones with gene therapy for SMA
European Pharmaceutical Review
MAY 11, 2023
We’ve achieved milestones no other gene therapy has accomplished to date by establishing flexible, tailored solutions enabling rapid access. Rare, genetic diseases like SMA are prime targets for gene therapy, but by their very nature, early signs can be difficult to recognise, delaying diagnosis and treatment.
70 
Let's personalize your content